ebomi
Colour theme
Sign in
Insider · CIK 0001478831

Stein Jeffrey

CIK 0001478831 Name as filed on the most recent filing

Filed as Stein Jeffrey (18)

23 transaction lines · from 18 filings · filed 2015-04-21 to 2026-03-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

23 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-03-02 P, Open-market purchase Ideaya Biosciences, Inc.IDYA 1,647,890, acquired Open Form 4 filing 0001610717-26-000078
2024-06-07 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 105,680, acquired Open Form 4 filing 0001628280-24-027720
2023-08-08 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 47,885, acquired Open Form 4 filing 0001610618-23-000081
2023-03-27 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 51,855, acquired Open Form 4 filing 0001610618-23-000026
2023-02-21 S, Open-market sale Paratek Pharmaceuticals, Inc.PRTK 13,300, disposed Open Form 4 filing 0000904454-23-000178
2021-11-12 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 79,530, acquired Open Form 4 filing 0001610618-21-000108
2021-08-19 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 17,871, acquired Open Form 4 filing 0001209191-21-052546
2021-08-18 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 68,884, acquired Open Form 4 filing 0001209191-21-052546
2020-11-10 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 100,015, acquired Open Form 4 filing 0001478831-26-000004
2020-11-10 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 100,015, acquired Open Form 4 filing 0001209191-20-057807
2019-09-24 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 100,102, acquired Open Form 4 filing 0001209191-19-050923
2019-02-15 S, Open-market sale Paratek Pharmaceuticals, Inc.PRTK 24,098, disposed Open Form 4 filing 0000904454-19-000256
2018-05-23 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 1,000,000, acquired Open Form 4 filing 0001209191-18-033073
2017-09-12 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 49,839, acquired Open Form 4 filing 0001478831-26-000004
2017-09-12 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 49,907, acquired Open Form 4 filing 0001209191-17-052467
2017-06-05 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 89,211, acquired Open Form 4 filing 0001478831-26-000004
2017-06-05 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 89,211, acquired Open Form 4 filing 0001209191-17-038321
2017-03-31 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 99,975, acquired Open Form 4 filing 0001478831-26-000004
2017-03-31 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 99,975, acquired Open Form 4 filing 0001209191-17-024799
2016-05-20 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 49,608, acquired Open Form 4 filing 0001209191-16-122617
2015-11-25 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 20,280, acquired Open Form 4 filing 0001209191-15-082349
2015-11-24 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 80,838, acquired Open Form 4 filing 0001209191-15-082349
2015-04-20 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 6,720, acquired Open Form 4 filing 0001209191-15-035323

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 21
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Stein Jeffrey, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001478831

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.